Granules India receives USFDA approval for Potassium Chloride for Oral Solution

30 Jan 2022 , 01:33 AM

Granules India announced today that the US Food Drug Administration US FDA has approved the Abbreviated New Drug Application ANDA filed by Granules Pharmaceuticals Inc GPI a wholly-owned foreign subsidiary of Granules India for Potassium Chloride for Oral Solution USP 20 mEq Potassium chloride is used to prevent or to treat low blood levels of potassium hypokalemia It is bioequivalent to the reference listed drug product Potassium Chloride for Oral Solution 20 mEq of Pharma Research Software Solution LLC The product would be available for the US market shortly